September 18: The Continued Influence of PTAB Proceedings on Bio/Pharma Patents

Inter Partes Review (IPR) and Post-Grant Review (PGR) proceedings before the Patent Trial and Appeal Board (PTAB) have become established mechanisms to challenge bio/pharma patents. But these proceedings are still very young and continually evolving. Many recent changes, including the Supreme Court’s SAS decision and the PTAB’s proposed rulemaking regarding claim construction, and even Senator Hatch’s suggested legislative changes are having /will have a significant impact on the strategies used by both petitioners and patent owners in these PTAB proceedings – particularly in the bio/pharma space. Join us as we discuss the following topics:

• A review of how bio/pharma patents have fared before the PTAB;
• An analysis of how PTAB proceedings are impacting ANDA and biosimilar litigations;
• A discussion of how the Supreme Court’s recent SAS decision is impacting PTAB invalidity proceedings in the bio/pharma space;
• A discussion of how the PTAB’s proposed rulemaking regarding the claim construction standard could impact bio/pharma patents; and
• A discussion regarding potential legislative action to alter the impact of PTAB proceedings on ANDA litigation.

Title:
The Continued Influence of PTAB Proceedings on Bio/Pharma Patents 
When/Where:
Tuesday, September 18, 2018

11:00 am Eastern Daylight Time 

10:00 am Central Daylight Time

8:00 am Pacific Daylight Time 

Live MBHB Webinar - Register Now!
Duration:
1 hour 15 minutes

By:

McDonnell Boehnen Hulbert & Berghoff LLP  committed to educating clients and friends of the firm with respect to significant developments and trends in the areas of intellectual property law.

Presenter(s): 
MBHB partner(s) Alison Baldwin and Paula Fritsch, Ph.D.
Cost:
While there is no fee to participate, all attendees must register in advance
Presenter(s): MBHB partners Alison Baldwin and Paula Fritsch, Ph.D.
Credit:
In order to receive MCLE credit, all attendees must participate online AND individually.
MCLE credit is pending for the states of California, Illinois, New Jersey,* New York,* North Carolina and Virginia (*via reciprocity).
More Information And Registration